Complement inhibitors selectively attenuate injury following administration of cobra venom factor to rats

Autoria(s): Proctor, Lavinia M.; Strachan, Anna J.; Woodruff, Trent M.; Mahadevan, Indumathy B.; Williams, H. Ming; Shiels, Ian A.; Taylor, Stephen M.
Data(s)

01/08/2006
Identificador

http://espace.library.uq.edu.au/view/UQ:79755
Idioma(s)

eng
Publicador

Elsevier Science
Palavras-Chave #Immunology #Pharmacology & Pharmacy #Complement #Cobra Venom Factor #C3a #C5a #C5a Antagonist #C5a Receptor Antagonist #Ischemia-reperfusion Injury #C3a Receptor #Intravascular Activation #Systemic Activation #Rosmarinic Acid #Lung Injury #Anaphylatoxin #Potent #Inflammation #Acute Lung Injury #C1 #0304 Medicinal and Biomolecular Chemistry #1115 Pharmacology and Pharmaceutical Sciences
Tipo

Journal Article
Acesso ao item digital